Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.
Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research.
Virax Biolabs partners with Europa Biosite to distribute ImmuneSelect for research use, focusing on T-cell immunity and post-viral syndromes, including Long COVID.
Virax Biolabs stock is trading higher on Wednesday after the company announced it entered into a distribution agreement with a supplier of RT-PCR Mpox detection kits.
Virax Biolabs has signed a distribution agreement to commercialize RT PCR Mpox virus detection kits in Europe and Gulf countries, amid a WHO-declared international health emergency due to rising mpox cases.
